Although COX-2 deletion attenuates HF diet-induced inflammation in liver and adipose tissue, it is not effective in ameliorating obesity or obesity-linked metabolic disorders. The gene discussed is PTGS2; the disease is obesity due to melanocortin 4 receptor deficiency.